Article metrics

Protocol for the CONVERT trial—Concurrent ONce-daily VErsus twice-daily RadioTherapy: an international 2-arm randomised controlled trial of concurrent chemoradiotherapy comparing twice-daily and once-daily radiotherapy schedules in patients with limited stage small cell lung cancer (LS-SCLC) and good performance status

 

Online download statistics by month:

Online download statistics by month: January 2018 to April 2024

AbstractFullPdf
Jan 201812812843
Feb 201812112229
Mar 201815215540
Apr 201815515538
May 201814514652
Jun 201813213237
Jul 201814413846
Aug 201812311541
Sep 201811611631
Oct 201811711736
Nov 201814414245
Dec 2018989643
Jan 201913913949
Feb 201911711036
Mar 201914913746
Apr 201918117144
May 201916014947
Jun 201914814043
Jul 201914113533
Aug 201915813036
Oct 201918516752
Nov 201912911335
Dec 201912011226
Jan 202012211628
Feb 202016615836
Mar 202019016436
May 202012812343
Jun 202013812833
Jul 20201039773
Aug 202014111848
Sep 20201139736
Oct 202017315573
Nov 202013811653
Dec 20201069563
Jan 202112010846
Feb 20211029841
Mar 202118417966
Apr 202115113077
May 202113413260
Jun 202113614441
Jul 2021959736
Aug 2021949749
Sep 202114515258
Oct 202114113856
Nov 2021454038
Dec 202118018362
Jan 202216216535
Feb 202210110344
Mar 202214814647
Apr 202213013442
May 202216015553
Jun 202212511243
Jul 202213012139
Aug 202214114441
Sep 2022918843
Oct 2022979330
Nov 202215013551
Dec 202211210531
Jan 202313312455
Feb 202315215145
Mar 202320219265
Apr 202315914265
May 202317617965
Jun 202318217837
Jul 202316315251
Aug 202314514635
Sep 202312011730
Oct 202315113731
Nov 202315115048
Dec 202315215729
Jan 2024727130
Feb 202412511240
Mar 202420720170
Apr 202414311038
Total1022797503313